416 related articles for article (PubMed ID: 30138110)
1. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey.
Wang M; Zhu J; Lubman DM; Gao C
Clin Chem Lab Med; 2019 Mar; 57(4):407-416. PubMed ID: 30138110
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
3. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
4. In silico approaches for unveiling novel glycobiomarkers in cancer.
Azevedo R; Silva AMN; Reis CA; Santos LL; Ferreira JA
J Proteomics; 2018 Jan; 171():95-106. PubMed ID: 28782717
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
6. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
Guo Y; Jia W; Yang J; Zhan X
Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation and cancer: moving glycomics to the forefront.
Drake RR
Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
[TBL] [Abstract][Full Text] [Related]
8. Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.
Muthu M; Chun S; Gopal J; Anthonydhason V; Haga SW; Jacintha Prameela Devadoss A; Oh JW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302373
[TBL] [Abstract][Full Text] [Related]
9. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
[TBL] [Abstract][Full Text] [Related]
10. Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery.
Kim YS; Yoo HS; Ko JH
Protein Pept Lett; 2009; 16(5):499-507. PubMed ID: 19442229
[TBL] [Abstract][Full Text] [Related]
11. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.
Chik JH; Zhou J; Moh ES; Christopherson R; Clarke SJ; Molloy MP; Packer NH
J Proteomics; 2014 Aug; 108():146-62. PubMed ID: 24840470
[TBL] [Abstract][Full Text] [Related]
13. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
14. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
Miura Y; Endo T
Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
Díaz-Fernández A; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ
Anal Bioanal Chem; 2018 Mar; 410(8):2059-2065. PubMed ID: 29353432
[TBL] [Abstract][Full Text] [Related]
16. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery.
Doud EH; Yeh ES
Technol Cancer Res Treat; 2023; 22():15330338221148811. PubMed ID: 36740994
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
[TBL] [Abstract][Full Text] [Related]
19. Lectin biosensors in cancer glycan biomarker detection.
Silva MLS
Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of Cancer Extracellular Vesicles: Capture Strategies, Functional Roles and Potential Clinical Applications.
Martins ÁM; Ramos CC; Freitas D; Reis CA
Cells; 2021 Jan; 10(1):. PubMed ID: 33430152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
